register

News & Trends - Biotechnology

Coronavirus holds very grave world threat: WHO

Health Industry Hub | February 13, 2020 |

China’s coronavirus outbreak poses a “very grave threat for the rest of the world”, the head of the World Health Organisation says.

WHO director-general Tedros Adhanom Ghebreyesus on Tuesday launched an appeal for sharing virus samples and speeding up research into drugs and vaccines to combat the epidemic.

He was addressing the start of a two-day meeting aimed at accelerating development of drugs, diagnostics and vaccines against the flu-like virus amid growing concerns about its ability to spread.

To date China has reported 42,708 confirmed cases, including 1017 deaths, Tedros said.

“With 99 per cent of cases in China, this remains very much an emergency for that country but one that holds a very grave threat for the rest of the world,” he told more than 400 researchers and national authorities.

Tedros, speaking to reporters, referred to “some concerning instances of onward transmission from people with no travel history to China”, citing cases this week in France and Britain.

Five British nationals were diagnosed with the coronavirus in France after staying in the same ski chalet with a person who had been in Singapore.

“The detection of this small number of cases could be the spark that becomes a bigger fire. But for now it’s only a spark. Our objective remains containment,” he said.

Hong Kong residents evacuated from a residential building where a man and woman confirmed with coronavirus live had tested negative, authorities said, easing concerns of a cluster.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our proven digital media solutions, developed by industry for industry.

Many questions remain about the origin of the virus, which emerged at a wildlife market in the central Chinese city of Wuhan in December and is spread by coughing or sneezing.

“We hope one of the outcomes of this meeting will be an agreed roadmap for research around which researchers and donors will align,” Tedros told the meeting.

“The bottom line is solidarity, solidarity, solidarity. That is especially true in relation to sharing of samples and sequences,” Tedros said.

“To defeat this outbreak, we need open and equitable sharing, according to the principles of fairness and equity.”

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


News & Trends - MedTech & Diagnostics

Federal government invests in Siemens Healthineers scanner to 'reduce wait times' for cancer diagnosis

Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]

More


News & Trends - MedTech & Diagnostics

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]

More


News & Trends - Biotechnology

CSL's world-first gene therapy heads for MSAC assessment

CSL’s world-first gene therapy heads for MSAC evaluation

Health Industry Hub | April 23, 2024 |

Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]

More


This content is copyright protected. Please subscribe to gain access.